The CUSA Clarity Bone Tip Study

NCT ID: NCT04300075

Last Updated: 2023-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-30

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the Study is to investigate the clinical performance and surgeon preferences of the CUSA Clarity Bone Tip during skull base surgery with removal of bony, and other cranial calcified tissue.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cranial Skull Base Bone Removal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CUSABT

Subject receives use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery

CUSABT

Intervention Type DEVICE

Subject receives use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CUSABT

Subject receives use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is at least 18 years of age
* Subject requires a cranial skull base procedure involving removal of bone with ultrasonic aspirator
* Subject is an appropriate candidate to receive use of the CUSA Clarity Bone Tip product during cranial skull base bone removal surgery, per the study surgeon
* Subject signed the IRB/EC-approved informed consent form demonstrating that the subject is willing and able to participate in this clinical study and to comply with all study procedures

Exclusion Criteria

* Subject is currently pregnant or plans to become pregnant prior to the study index surgery
* Subject has any significant medical condition that in the opinion of the investigator will interfere with protocol evaluation and participation
* Subject's surgical plan includes utilizing CUSA Clarity Bone Tip for bone removal anywhere besides the cranial skull base in an open craniotomy (e.g. transsphenoidal approach or spinal procedures).
* Subject is a prisoner or member of a different vulnerable population that should not be included in the study per the investigator or ethics committee.


* Surgeon does not utilize CUSA Clarity Bone Tip for cranial skull base bone removal during surgery or utilizes CUSA Clarity Bone Tip anywhere else besides the cranial skull base
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Integra LifeSciences Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jason Marzuola

Role: STUDY_DIRECTOR

Integra LifeSciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Barbara-Klinik Hamm-Heessen Klinik für Neurochirurgie

Hamm, , Germany

Site Status

Universitätsklinikum Münster Klinik und Poliklinik für Neurochirurgie

Münster, , Germany

Site Status

General Hospital of Athens "Georgios Gennimatas"

Athens, , Greece

Site Status

Azienda Ospedaliero-Universitaria Consorziale Policlinico

Bari, , Italy

Site Status

Ospedale di Treviso

Treviso, , Italy

Site Status

Azienda Sanitaria Universitaria Integrata di Udine

Udine, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Greece Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C-CUSABT-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.